| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Shao Wei-Ming | EVP & General Counsel | C/O MICROSTRATEGY INCORPORATED, 1850 TOWERS CRESCENT PLAZA, TYSONS CORNER | /s/ Allein Sabel, Attorney-in-Fact | 2025-07-11 | 0001663488 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MSTR | Class A Common Stock | Options Exercise | $809K | +20K | +157.16% | $40.46 | 32.7K | Jul 9, 2025 | Direct | |
| transaction | MSTR | Class A Common Stock | Options Exercise | $219K | +12.5K | +38.2% | $17.50 | 45.2K | Jul 9, 2025 | Direct | |
| transaction | MSTR | Class A Common Stock | Sale | -$13M | -32.5K | -71.86% | $401.47 | 12.7K | Jul 9, 2025 | Direct | F1 |
| transaction | MSTR | Class A Common Stock | Options Exercise | $809K | +20K | +157.16% | $40.46 | 32.7K | Jul 10, 2025 | Direct | |
| transaction | MSTR | Class A Common Stock | Sale | -$495K | -1.2K | -3.67% | $412.90 | 31.5K | Jul 10, 2025 | Direct | F2 |
| transaction | MSTR | Class A Common Stock | Sale | -$1M | -2.43K | -7.7% | $413.82 | 29.1K | Jul 10, 2025 | Direct | F3 |
| transaction | MSTR | Class A Common Stock | Sale | -$498K | -1.2K | -4.12% | $414.95 | 27.9K | Jul 10, 2025 | Direct | F4 |
| transaction | MSTR | Class A Common Stock | Sale | -$250K | -600 | -2.15% | $415.95 | 27.3K | Jul 10, 2025 | Direct | F5 |
| transaction | MSTR | Class A Common Stock | Sale | -$542K | -1.3K | -4.76% | $417.08 | 26K | Jul 10, 2025 | Direct | F6 |
| transaction | MSTR | Class A Common Stock | Sale | -$251K | -600 | -2.31% | $418.34 | 25.4K | Jul 10, 2025 | Direct | F7 |
| transaction | MSTR | Class A Common Stock | Sale | -$471K | -1.12K | -4.42% | $419.40 | 24.3K | Jul 10, 2025 | Direct | F8 |
| transaction | MSTR | Class A Common Stock | Sale | -$2.98M | -7.09K | -29.2% | $420.40 | 17.2K | Jul 10, 2025 | Direct | F9 |
| transaction | MSTR | Class A Common Stock | Sale | -$1.7M | -4.05K | -23.53% | $421.43 | 13.1K | Jul 10, 2025 | Direct | F10 |
| transaction | MSTR | Class A Common Stock | Sale | -$176K | -418 | -3.18% | $422.14 | 12.7K | Jul 10, 2025 | Direct | F11 |
| holding | MSTR | Series A Perpetual Stride Preferred Stock | 3.53K | Jul 9, 2025 | Direct | ||||||
| holding | MSTR | Series A Perpetual Strife Preferred Stock | 500 | Jul 9, 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MSTR | Employee Stock Option (Right to buy) | Options Exercise | $0 | -20K | -10% | $0.00 | 180K | Jul 9, 2025 | Class A Common Stock | 20K | $40.46 | Direct | F12 |
| transaction | MSTR | Employee Stock Option (Right to buy) | Options Exercise | $0 | -12.5K | -11.11% | $0.00 | 100K | Jul 9, 2025 | Class A Common Stock | 12.5K | $17.50 | Direct | F13 |
| transaction | MSTR | Employee Stock Option (Right to buy) | Options Exercise | $0 | -20K | -11.11% | $0.00 | 160K | Jul 10, 2025 | Class A Common Stock | 20K | $40.46 | Direct | F14 |
| Id | Content |
|---|---|
| F1 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.31 to $402.00, inclusive. The reporting person undertakes to provide to MicroStrategy Incorporated d/b/a Strategy ("Strategy"), any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $412.37 to $413.26, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $413.39 to $414.30, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F4 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $414.50 to $415.49, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F5 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $415.50 to $416.42, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F6 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $416.94 to $417.24, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F7 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $417.97 to $418.82, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F8 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $419.00 to $419.76, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F9 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $420.00 to $420.90, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F10 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $421.00 to $421.95, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F11 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $422.05 to $422.24, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. |
| F12 | The 20,000 shares exercised on July 9, 2025 pursuant to this option vested on February 17, 2023. Of the remaining 180,000 shares subject to this option, 30,000 shares vested on February 17, 2023, 50,000 shares vested on February 17, 2024, 50,000 shares vested on February 17, 2025 and 50,000 shares are scheduled to vest on February 17, 2026. |
| F13 | The 12,500 shares exercised on July 9, 2025 pursuant to this option vested on November 10, 2024. Of the remaining 100,000 shares subject to this option, 50,000 shares are scheduled to vest on November 10, 2025 and 50,000 shares are scheduled to vest on November 10, 2026. |
| F14 | The 20,000 shares exercised on July 10, 2025 pursuant to this option vested on February 17, 2023. Of the remaining 160,000 shares subject to this option, 10,000 shares vested on February 17, 2023, 50,000 shares vested on February 17, 2024, 50,000 shares vested on February 17, 2025 and 50,000 shares are scheduled to vest on February 17, 2026. |